SEATTLE — There's new hope for people in the early stages of Alzheimer's disease. A new medication called donanemab appears ...

The causes of Alzheimer’s disease have long puzzled researchers, especially when most older adults show signs of the illness ...

When the NIH canceled grants in March related to diversity, equity and inclusion, or DEI, some Alzheimer’s studies were swept ...

A new study found that a gene recently recognized as a biomarker for Alzheimer's disease is actually a cause of it, due to ...

Not surprisingly, finding the magic bullet has become the holy grail for Alzheimer’s researchers. But it’s proving to be an ...

Alzheimer’s disease is commonly thought of as an older person’s illness. But new research from Columbia University and the ...

An extended family in that South American country has a devastating genetic variant that triggers early-onset dementia. "They ...

Researchers have developed a tau-targeting vaccine that could help prevent the progression of Alzheimer’s disease by ...

The second U.S. drug shown to slow the progression of early Alzheimer's has arrived in Seattle-area clinics. One of the first ...

A new clinical trial has found that a common brain stimulation technique may help slow down cognitive and functional decline ...

HudsonAlpha launched a pilot study, Hope AD, to see how genetics and lifestyle influence a person’s risk of developing ...

Can you kindly explain the differences between Alzheimer’ disease, dementia, cognitive impairment and memory loss?Raimi (by SMS) Dementia is a catch-all term and covers all types of brain problems.